Back
Akero Therapeutics Stock Predictions
Sell
34
AKRO
Akero Therapeutics
Last Price:
19.94
Seasonality Move:
19.74%
7 Day Trial
ALL ACCESS PASS
$
7
Akero Therapeutics Stock Forecast
- Over the next 52 weeks, Akero Therapeutics has on average historically risen by 77.2% based on the past 4 years of stock performance.
- Akero Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Akero Therapeutics Stock Undervalued?
The current Akero Therapeutics [AKRO] share price is $19.92. The Score for AKRO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal. - AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Akero Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Akero Therapeutics has on average historically risen by 77.2% based on the past 4 years of stock performance.
Akero Therapeutics Stock Rating
Sell
34
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics overpriced?
- Akero Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Akero Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com
52-Week Data
52-Week High:
58.38
52-Week Low:
11.25
Prediction Charts
Market Cap:
1.38B
Price in USD:
19.92
Volume:
457.66K
Beta:
-0.29
Technical Analysis
SMA50:
22.86
SMA100:
23.04
SMA200:
27.08
52-Wk Change:
-56.97%
Stock Predictions
-
Is Akero Therapeutics stock public?
Yes, Akero Therapeutics is a publicly traded company. -
What is the Akero Therapeutics stock quote today?
The Akero Therapeutics stock price is 19.92 USD today. -
How to buy Akero Therapeutics stock online?
You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 19.99 | 19.89 | 20.33 | 19.33 |
May-1 | 20.00 | 20.08 | 20.64 | 19.72 |
May-2 | 20.44 | 19.69 | 20.44 | 19.64 |
May-3 | 20.32 | 19.66 | 20.75 | 19.63 |
May-6 | 19.93 | 22.13 | 22.26 | 19.93 |
May-7 | 22.18 | 22.03 | 22.25 | 21.54 |
May-8 | 21.57 | 21.02 | 21.91 | 20.58 |
May-9 | 21.20 | 20.80 | 21.21 | 20.54 |
May-10 | 21.35 | 19.65 | 21.45 | 19.59 |
May-13 | 19.66 | 20.62 | 21.46 | 19.46 |
May-14 | 21.12 | 20.30 | 21.51 | 20.27 |
May-15 | 21.35 | 21.07 | 21.74 | 20.49 |
May-16 | 20.96 | 20.73 | 21.10 | 20.33 |
May-17 | 20.79 | 19.92 | 20.82 | 19.76 |
Akero Therapeutics Earnings
Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Akero Therapeutics Forecast Revenue Growth
Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.06 per share, and a decrease next year of $0.47 per share.
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.